Sunday, February 20, 2005

The painful battle over the 'wonder

From the Globe and Mail:
The night before Merck & Co. officials pulled Vioxx off the market last September, after their popular painkiller was found to double the risk of heart attack and stroke, they called a small, trusted group of scientists for advice.

Claire Bombardier was one of them. Director of rheumatology at the University of Toronto and holder of a prestigious Canada research chair in the field, Dr. Bombardier has been a consultant to Merck on Vioxx since 1997. more...

No comments: